期刊文献+

壳聚糖/肝素雷帕霉素药物洗脱支架对猪冠状动脉早期快速内皮化及抗血栓的作用 被引量:5

Effect of Chitosan/Heparin Rapamycin Drug Eluting Stent on Accelerating the Early Phase Re-Endothelialization and Anti-Thrombus Properties in Porcine Coronary Artery
下载PDF
导出
摘要 目的:明确壳聚糖/肝素雷帕霉素药物洗脱支架(LBL-PLA-RAP支架)对猪冠状动脉(冠脉)早期快速内皮化及抗血栓的作用。方法:共选取9只小香猪,每种模型(静脉分流模型、高血栓负荷模型、球囊损伤模型)用3只小香猪,每只猪冠脉内分别置入3种不同的支架(LBL-PLA-RAP支架、壳聚糖/肝素涂层膜支架、裸金属支架)。通过动静脉分流模型与高血栓负荷模型验证LBL-PLA-RAP支架的抗血栓作用,通过1周猪冠脉球囊损伤模型,观察LBL-PLA-RAP支架早期内皮化的作用。结果:LBL-PLA-RAP支架在动静脉分流模型与高血栓负荷模型中较裸金属支架有较好的抗血栓作用,且在1周的球囊损伤模型中显示较好的内皮化作用。结论:LBL-PLA-RAP支架具有强大的抗血栓及能够在极早期促进支架内皮化。 Objective: To clarify the effect of ehitosan/heparin rapamycin drug eluting stent on accelerating the in-stent early phase re-endothelialization and anti-thrombus properties in porcine coronary artery. Methods: A total of 9 small pigs were divided into 3 models, Arterio-venous shunt model, High thrombosis load model, and coronary artery balloon injury model, n=3 in each model. Each animal was implanted in 3 stents as chitosan/heparin rapamyein drug eluting stent, chitosan/heparin coating stent, and bare metal stent. The anti-thrombus effect of chitosan/ heparin rapamycin drug eluting stent was examined with Arterio-venous shunt and High thrombosis load models, the early phase re-endothelialization effect of chitosan/heparin rapamycin drug eluting stent was evaluated with 1 week-coronary artery balloon injury model. Results: Compared with bare meta! stent, chitosan/heparin rapamycin drug eluting stent presented the better anti- thrombus effect in Arterio-venous shunt and High load thrombosis models, it also showed better re-endothelialization effect in 1 week-coronary artery balloon injury model of animals. Conclusion: Chitosan/heparin rapamycin drug eluting stent has strong in-stent anti-thrombus effect and may improve the early phase re-endothelialization in experimental porcine coronary artery.
出处 《中国循环杂志》 CSCD 北大核心 2013年第3期218-221,共4页 Chinese Circulation Journal
基金 上海市医学重点专科心内科(05-II026) 上海市普陀区自主创新项目(B82) 上海市教委项目
关键词 药物洗脱支架 层层自组装 壳聚糖 肝素 内皮化 血栓 Drug eluting stent Layer-by-layer self-assembly Chitosan/heparin Endothelialization Thrombus
  • 相关文献

参考文献16

  • 1Brodle B, Pokharel Y, Fleishman N, et a|.Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drng-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience. JACC Cardiovasc Interv, 2011, 4: 30-38.
  • 2Blich M, Zeidan-Shwiri T, Petcherski S, et al. Incidence, predictors and outcome of drug-eluting stent thrombosis in real-world practice. J Invasive Cardiol, 2010, 22: 461-464.
  • 3Holmes DR, Kereiakes DJ, Garg S, et al. Stent thrombosis. J Am Coil Cardiol, 2010, 56: 1357-1365.
  • 4Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA, 2005, 293: 2126-2130.
  • 5Ong AT, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coil Cardiol, 2005, 45: 2088-2092.
  • 6McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug- eluting coronary stents after discontinuation of antiplatelet therapy. Lancet, 2004, 364: 1519-1521.
  • 7Virmani R, Kolodgie FD, Farh A, et al. Drug eluting stents: are human and animal studies comparable ? Heart, 2003, 89: 133-138.
  • 8VirmaniR, Guagliumi G, FarbA, et al. Localized hypersensitivcty and late coronary thrombosis secondary to asirolimus-eluting stent: should we be cautious? Circulation, 2004,109:701-705.
  • 9Joner M, Finn AV, Farb A,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J AM Coil Cardiol, 2006,48:193 -202.
  • 10Oyabu J, Ueda Y, Ogasawara N, et aL Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J, 2006,152:! 168-1174.

二级参考文献25

  • 1邱洪,高润霖,唐智荣,孟亮,兆恒,阮英卯,赵红,杨跃进,陈纪林,陈在嘉.Mytrolimus药物洗脱支架预防支架内再狭窄的实验研究[J].中华心血管病杂志,2005,33(6):561-564. 被引量:15
  • 2Schfimig A, Dibra A, Windecker S, et al. A meta-analysis of 16 ran- domized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coil Cardiol, 2007,50 ( 14 ) : 1373-1380.
  • 3Daemen J, Wenaweser P,Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet,2007,569(9562) :667-678.
  • 4Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implanta- tion of first-generation drug-eluting stents: a cause for concern. Circu- lation ,2007,115 ( 11 ) : 1440-1455.
  • 5Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug elu- ting stents : importance of delayed healing. Arterioscler Thromb Yasc Biol,2007,27 ( 7 ) : 1500-1510.
  • 6Hietala EM, Maasilta P, Juuti H, et al. Platelet deposition on stainless steel, spiral, and braided polylactide stents. A comparative study. Thromb Haemost,2004,92(6) : 1394-1401.
  • 7Babinska A, Markell MS, Salifu MO, et al. Enhancement of human platelet aggregation and secretion induced by rapamycin. Nephrol Dial Transplant, 1998,13 (12) :3153-3159.
  • 8De Jong WH, Eelco Bergsma J, Robinson JE, et al. Tissue response topartially in vitro predegraded poly-L-lactide implants. Biomaterials, 2005,26 (14) : 1781-1791.
  • 9. Commandeur S, van Beusekom HM, van der Giessen WJ. Polymers, drug release, and drug-eluting stents. J Interv Cardio1,2006,19 ( 6 ) : 500-506.
  • 10Ormiston JA, Abizaid A, Spertus J, et al. Six-month results of the NE- VO Res-Elution I ( NEVO RES-I) trial: a randomized, multieenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Libert6 paelitaxel-eluting stent in de novo native coronary ar- tery lesions. Circ Cardiovase Interv ,2010,3(6) :556-564.

共引文献10

同被引文献97

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部